Body Health CalculatorHOMA-IR vs A1C: Insulin Resistance vs Long-Term Glucose
HOMA-IR estimates insulin resistance from fasting glucose and insulin. A1c reflects average blood sugar over two to three months. HOMA-IR can rise before A1c crosses the prediabetes range.
Last updated: September 2026
Markdown version for AI agents and developers
Summary
HOMA-IR and hemoglobin A1c assess different facets of glucose metabolism. HOMA-IR (Homeostatic Model Assessment of Insulin Resistance) estimates how much insulin your pancreas must produce to maintain fasting glucose. A1c reflects the average blood sugar concentration over two to three months.
Insulin resistance can precede overt hyperglycemia by years. HOMA-IR may rise while A1c still sits in the normal range, which makes the two markers complementary rather than interchangeable.
HOMA-IR vs A1c comparison
| HOMA-IR | Hemoglobin A1c | |
|---|---|---|
| Primary signal | Insulin resistance (fasting) | Long-term average glucose |
| Inputs required | Fasting glucose + fasting insulin | Single blood draw, no fasting |
| Typical units | Dimensionless index (formula-based) | Percentage (%) |
| Elevated threshold (common) | >2.5 to 3.0 (population-dependent) | ≥5.7% prediabetes, ≥6.5% diabetes |
| Detects early IR | Often yes, before A1c rises | No, lags until glucose averages climb |
| Affected by insulin therapy | Yes (interpret with caution) | No direct insulin effect on assay |
When to use HOMA-IR
Use HOMA-IR when evaluating metabolic syndrome, polycystic ovary syndrome, non-alcoholic fatty liver disease, or family history of type 2 diabetes with normal A1c. The index helps identify insulin resistance before average glucose crosses diagnostic thresholds.
HOMA-IR = (fasting insulin μU/mL × fasting glucose mg/dL) / 405. Some labs report glucose in mmol/L and use a different divisor (22.5). Confirm unit consistency before calculating.
Values above roughly 2.5 to 3.0 suggest significant insulin resistance in many epidemiologic cohorts, though optimal cutoffs vary by ethnicity and assay method. Repeat testing on a separate day reduces noise from acute illness or poor sleep.
Draw fasting insulin and glucose from the same venipuncture when possible. HOMA-IR assumes paired samples taken after at least eight hours without caloric intake.
When to use A1c
A1c is the standard for diabetes diagnosis and long-term glycemic monitoring. It requires no fasting, integrates weeks of exposure, and correlates with microvascular complication risk in trial data.
The ADA recommends A1c at least twice yearly for stable diabetic patients and quarterly when treatment changes or targets are missed. Prediabetes at 5.7 to 6.4 percent triggers lifestyle intervention referral under CDC prevention program criteria.
A1c alone misses post-meal spikes and hypoglycemia. It also becomes unreliable with hemoglobin variants, recent transfusion, iron deficiency, and certain ethnic backgrounds where glycation rates differ at the same mean glucose.
Gestational diabetes screening uses glucose challenge testing rather than A1c in early pregnancy, so prenatal care follows separate protocols from standard adult monitoring.
Insulin resistance before elevated A1c
In early metabolic dysfunction, beta cells compensate by secreting more insulin, keeping fasting glucose and A1c normal while HOMA-IR climbs. This hyperinsulinemic-euglycemic phase can last years.
When compensation fails, fasting glucose and A1c begin rising together. HOMA-IR at that stage may plateau or fall as insulin production declines in later type 2 diabetes progression.
Combining HOMA-IR, fasting glucose, triglycerides, HDL, and waist circumference aligns with metabolic syndrome criteria and gives a fuller picture than any single marker.
Waist circumference and triglyceride-to-HDL ratio often move in parallel with HOMA-IR during this transition, which is why metabolic syndrome screening bundles multiple markers rather than relying on glucose alone.
Using HOMA-IR and A1c together
Screen with A1c and fasting glucose for diabetes case finding per ADA guidelines. Add HOMA-IR when insulin resistance is suspected despite normal A1c, or when tailoring weight loss and exercise interventions for PCOS and NAFLD.
Track A1c every three to six months to judge whether lifestyle or medication changes improve average glucose. Repeat HOMA-IR less frequently unless research or specialist care requires it, because fasting insulin assays vary between labs.
Weight loss of 5 to 7 percent body weight in prediabetes improves both HOMA-IR and A1c in DPP trial follow-up data.
Resistance training improves insulin sensitivity independent of scale weight change, so HOMA-IR may fall while A1c stays flat until dietary carbohydrate exposure also shifts.
Limitations
HOMA-IR assumes stable fasting steady state. It is invalid during exogenous insulin infusion, significant beta cell failure, or acute illness.
A1c is a lagging average and does not quantify insulin sensitivity directly.
Neither replaces oral glucose tolerance testing or CGM when diagnosis remains uncertain. Endocrinology referral is appropriate for discordant or conflicting results.
Fasting insulin assays are not standardized across laboratories the way A1c is. Compare HOMA-IR trends using the same lab when possible rather than absolute values from different facilities.